News

FDA Tracks Fake Avastin to Foreign Supply Distributed in U.S.


 

Medical practices that have obtained unapproved products from foreign sources, in particular from Volunteer Distribution and/or QSP, should stop using them and contact the FDA. These products should be retained and securely stored.

To report suspect counterfeit products and other suspect unapproved products obtained from Volunteer Distribution or QSP/Montana Health Care Solutions or other sources: Call FDA’s Office of Criminal Investigations (OCI) at 800-551-3989, or visit OCI’s website.

For information about this counterfeit medicine, see Roche’s statement.

Click here for more information about counterfeit medicines found in the United States.

Pages

Recommended Reading

Combining MRI With Prostate Ultrasound Biopsy Bests Biopsy Alone
MDedge Internal Medicine
Prostate Cancer Deaths: Annual Screen Not Superior to Usual Care
MDedge Internal Medicine
ASCO GU to Spotlight Prostate Cancer Drugs MDV3100 and Radium-223
MDedge Internal Medicine
MDV3100 Cuts Risk of Death in Advanced Prostate Cancer
MDedge Internal Medicine
ALSYMPCA Trial: Radium-223 Prolongs Life in Some Prostate Cancers
MDedge Internal Medicine
FDA Panel Rejects Denosumab Against Bone Metastasis in Prostate Cancer
MDedge Internal Medicine
Mild CKD Ups Risks of Renal, Urothelial Cancers
MDedge Internal Medicine
Everolimus Shrinks Angiomyolipomas from Tuberous Sclerosis Complex
MDedge Internal Medicine
Costs Don't Always Match Outcomes of Prostate Cancer Treatments
MDedge Internal Medicine
Vitamin E Supplements Linked to Increase in Prostate Cancer Risk
MDedge Internal Medicine